ES8603509A1 - Procedimiento para preparar compuestos esteroides 2-alfa-ciano-4 alfa,5 alfa epoxi-3-oxo y (2,3-d) hetero-sustituidos. - Google Patents

Procedimiento para preparar compuestos esteroides 2-alfa-ciano-4 alfa,5 alfa epoxi-3-oxo y (2,3-d) hetero-sustituidos.

Info

Publication number
ES8603509A1
ES8603509A1 ES537181A ES537181A ES8603509A1 ES 8603509 A1 ES8603509 A1 ES 8603509A1 ES 537181 A ES537181 A ES 537181A ES 537181 A ES537181 A ES 537181A ES 8603509 A1 ES8603509 A1 ES 8603509A1
Authority
ES
Spain
Prior art keywords
particle size
reduced particle
steroid
compoundshaving
size form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES537181A
Other languages
English (en)
Other versions
ES537181A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sterwin AG
Original Assignee
Sterwin AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterwin AG filed Critical Sterwin AG
Publication of ES537181A0 publication Critical patent/ES537181A0/es
Publication of ES8603509A1 publication Critical patent/ES8603509A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR COMPUESTOS ESTEROIDALES CON UN TAMAÑO DE PARTICULA DENTRO DE UNA GAMA DESEADA Y ESPECIFICA. CONSISTE EN DISOLVER COMPUESTOS ESTEROIDALES DE FORMULAS GENERALES (II) O (III) EN DIMETILFORMAMIDA O ACETONA Y PRECIPITAR EL COMPUESTO MEZCLANDOLO CON AGUA DURANTE UN PERIODO DE TIEMPO DE 4 A 10 MINUTOS, CONTROLANDO LAS CONDICIONES DE MEZCLA PARA PRODUCIR UN PRECIPITADO CON UN DIAMETRO DE VOLUMEN ESFERICO EQUIVALENTE MEDIO ENTRE 4 Y 12 MICRAS. ESTA GAMA DE TAMAÑOS DE PARTICULA POSEE UNA BIODISPONIBILIDAD OPTIMA.
ES537181A 1983-10-29 1984-10-29 Procedimiento para preparar compuestos esteroides 2-alfa-ciano-4 alfa,5 alfa epoxi-3-oxo y (2,3-d) hetero-sustituidos. Expired ES8603509A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838328929A GB8328929D0 (en) 1983-10-29 1983-10-29 Steroid compounds

Publications (2)

Publication Number Publication Date
ES537181A0 ES537181A0 (es) 1985-12-16
ES8603509A1 true ES8603509A1 (es) 1985-12-16

Family

ID=10550923

Family Applications (1)

Application Number Title Priority Date Filing Date
ES537181A Expired ES8603509A1 (es) 1983-10-29 1984-10-29 Procedimiento para preparar compuestos esteroides 2-alfa-ciano-4 alfa,5 alfa epoxi-3-oxo y (2,3-d) hetero-sustituidos.

Country Status (11)

Country Link
US (1) US4605517A (es)
EP (1) EP0142309B1 (es)
AT (1) ATE49217T1 (es)
DE (1) DE3480929D1 (es)
DK (1) DK511184A (es)
ES (1) ES8603509A1 (es)
FI (1) FI81362C (es)
GB (2) GB8328929D0 (es)
GR (1) GR80795B (es)
NO (1) NO159385C (es)
PT (1) PT79423B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8504486A1 (es) 1982-11-02 1985-05-01 Sterwin Ag Procedimiento de trituracion de compuestos esteroides
US6458811B1 (en) 1996-03-26 2002-10-01 Eli Lilly And Company Benzothiophenes formulations containing same and methods
UA72922C2 (uk) 1999-08-03 2005-05-16 Ліллі Айкос Ллк ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ З <font face="Symbol">b</font>-КАРБОЛІНОМ (ВАРІАНТИ) ТА СПОСІБ ЛІКУВАННЯ СЕКСУАЛЬНОЇ ДИСФУНКЦІЇ
GB2375958B (en) * 2001-04-09 2005-03-02 George Margetts The use of steroids to lower the levels of cortisol
CN100404545C (zh) * 2003-03-27 2008-07-23 尼科梅德有限责任公司 具有规定粒径的结晶环缩松的制备方法
MY143936A (en) * 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
GB2400554B (en) * 2003-04-16 2007-04-18 George Margetts Treatment of angiotensin II-induced cardiovascular disease
GB2414238B (en) * 2004-05-22 2006-12-13 Stegram Pharmaceuticals Ltd Method for the preparation of trilostane
CA2653384C (en) 2006-06-30 2017-03-14 Iceutica Pty Ltd Methods for the preparation of biologically active compounds in nanoparticulate form
CA3084564A1 (en) 2017-12-04 2019-06-13 Nanollose Limited Methods for producing a viscose dope from microbial cellulose

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB911815A (en) * 1958-03-24 1962-11-28 Sterling Drug Inc Steroid compounds and preparation thereof
NL241544A (es) * 1958-07-23
GB1009912A (en) * 1960-11-23 1965-11-17 Merck & Co Inc Steroid compounds
GB1123770A (en) * 1966-11-15 1968-08-14 Sterling Drug Inc 2-cyano-3-oxo-steroids
US4277409A (en) * 1977-03-18 1981-07-07 Roussel Uclaf Preparation of 9α-fluoro-16α-methyl-21-acetoxy-Δ1,4 -pregnadiene-11β-ol-3,20-dione
US4160027A (en) * 1977-12-20 1979-07-03 Sterling Drug Inc. Steroid cyanoketones and intermediates
US4391755A (en) * 1982-01-18 1983-07-05 E. R. Squibb & Sons, Inc. Steroid monohydrates, formulations containing same and method
ES8504486A1 (es) * 1982-11-02 1985-05-01 Sterwin Ag Procedimiento de trituracion de compuestos esteroides
US4459235A (en) * 1983-03-03 1984-07-10 G. D. Searle & Co. 2-Cyanosteroids

Also Published As

Publication number Publication date
GB2148899B (en) 1987-07-22
DK511184D0 (da) 1984-10-26
DE3480929D1 (de) 1990-02-08
FI844238L (fi) 1985-04-30
EP0142309B1 (en) 1990-01-03
PT79423B (en) 1986-11-13
EP0142309A3 (en) 1986-02-12
NO159385B (no) 1988-09-12
FI844238A0 (fi) 1984-10-29
NO159385C (no) 1988-12-21
NO844300L (no) 1985-04-30
FI81362B (fi) 1990-06-29
ES537181A0 (es) 1985-12-16
US4605517A (en) 1986-08-12
EP0142309A2 (en) 1985-05-22
GB2148899A (en) 1985-06-05
ATE49217T1 (de) 1990-01-15
GR80795B (en) 1985-03-01
DK511184A (da) 1985-04-30
PT79423A (en) 1984-11-01
FI81362C (fi) 1990-10-10
GB8328929D0 (en) 1983-11-30
GB8427300D0 (en) 1984-12-05

Similar Documents

Publication Publication Date Title
ES8603509A1 (es) Procedimiento para preparar compuestos esteroides 2-alfa-ciano-4 alfa,5 alfa epoxi-3-oxo y (2,3-d) hetero-sustituidos.
JPS5371189A (en) Suspension of organic polyhydroxyl compound including stable inorganic filler producing process thereof and method of using said suspension as component for producing polyurethan resin
GR80583B (en) Estran and androstan derivatives, method for the preparation thereof and preparations containing said compounds
JPS5233383A (en) Carcass disposing method and the device
JPS537939A (en) Process for errecting upper end final unit of structure
ES459262A1 (es) Un procedimiento para obtener compuestos de cefalosporina.
JPS523254A (en) Raking machine for sunken sand
JPS52144844A (en) End packing method for cease heater
JPS51125239A (en) Process for preparing new bytyrophenone derivatives
JPS51136678A (en) Process for preparing 5-((2-alkylamino-1-hydroxy)alkyl) carbostyril de rivatives
JPS51136684A (en) Process for preparing 5-((2-alkylamino-1-hydroxy) alkyl carbostyril de rivatives
JPS51113890A (en) Method for preparing novel cephalosporins
JPS5259189A (en) Preparation of pyrimido 5,4-d pyrimidine derivatibbes
JPS57131739A (en) Novel cyclohexanecarboxylic acid derivative
JPS51113881A (en) Method for preparing 3&#39;,(2&#39;)-substituted-5-fluorouridine derivatives
JPS5239110A (en) Rotor for electronic clock
JPS51133275A (en) A process for preparing carbostyril derivatives
JPS5283571A (en) Glutarimide derivatives
JPS52116490A (en) Novel 7alpha-methoxycephalosporanic acid derivatives and method of preparing the same
JPS52125169A (en) Tetrahydropyran-5-one derivatives and method of preparing the same
JPS51133284A (en) A process for preparing carbostyril derivatives
JPS51133280A (en) A process for preparing 3,4- dihydrocarbostyril derivatives
JPS5325737A (en) Low speed controlled voltage generating circuit for electronic fuel control unit
JPS51133283A (en) A process for preparing carbostyril derivatives
JPS5345806A (en) Shoulder ballast screening machine

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960401